US2004256276A1PendingUtilityA1

Container with spaced apart label

Priority: Feb 2, 1999Filed: Jun 2, 2004Published: Dec 23, 2004
Est. expiryFeb 2, 2019(expired)· nominal 20-yr term from priority
Inventors:Harry Flewitt
B65D 81/24B65D 23/14B65D 1/40B65D 1/0223
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A product comprising a container having a body defined by a container wall made of a plastics material, at least part of the container wall comprising spaced apart inner and outer walls, a label being located on the outer surface of the outer wall, the body having an internal cavity containing a medicament content and being bounded at least in part by the inner wall. Examples of containers are described, as are examples of typical medicament contents.

Claims

exact text as granted — not AI-modified
1 - 15 . (Canceled)  
     
     
         16 . A product comprising a double walled container, having a base wall and side walls extending upwardly from the base wall toward an upper mouth opening of the container, and the side walls are in the form of a double wall comprising a spaced apart inner wall and outer wall having a space between them, made of a plastics material, the container having an internal cavity containing a medicament content which is a fluid which incorporates a solvent vehicle, the medicament content being in contact with the inner wall, said cavity being bounded at least in part by the inner wall, a label applied by an adhesive to a part of the outer surface of the outer wall of which the inner surface of the part is separated from the inner wall by the space between the inner and outer walls, the space between the inner and outer walls being devoid of medicament content, and the base wall is a continuous base wall linking the inner and outer walls and closing the space between them.  
     
     
         17 . A product according to  claim 16  wherein the side walls are in the form of a continuous double wall extending the whole height of the internal cavity from the base wall to the mouth opening.  
     
     
         18 . A product according to  claim 16  comprising substantially cylindrical inner and substantially cylindrical outer walls, which are substantially concentric and coaxial.  
     
     
         19 . A product according to  claim 16  comprising a lower container part and an upper container part which fit together with a seal which does not allow leakage or contamination of the contents, such lower and upper container parts comprising respective lower and upper inner and outer wall parts of the container which fit together when the upper and lower container parts are fitted together.  
     
     
         20 . A product according to  claim 16  made of plastics material and having an inner wall thickness ca. 1-2 mm, and an outer wall thickness ca. 1-2.5 mm.  
     
     
         21 . A product according to  claim 16  wherein the medicament content is a fluid which incorporates a solvent vehicle.  
     
     
         22 . A product according to  claim 21  wherein the solvent vehicle is a pharmaceutically acceptable oily vehicle.  
     
     
         23 . A product according to  claim 22  wherein the oily vehicle is a monoglyceride, phospholipid, or a galactolipid.  
     
     
         24 . A product according to  claim 23  wherein the oily vehicle is selected from glycerol mono-oleate, glycerol monopalmitate and glycerol monostearate.  
     
     
         25 . A product according to  claim 22  containing a long-chain digylyceride.  
     
     
         26 . A product according to  claim 22  containing a fatty acid triglyceride.  
     
     
         27 . A product according to  claim 26  wherein the fatty acid triglyceride is caprylic/capric triglyceride (Tricaprylin).  
     
     
         28 . A product according to  claim 16  wherein the medicament content comprises calcium mupirocin, fractionated coconut oil, and glycerol mono-oleate.  
     
     
         29 . A product according to  claim 16  being a nasal spray container provided with means to deliver its medicament content to the nasal area of a user.

Join the waitlist — get patent alerts

Track US2004256276A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.